BioCentury | Feb 2, 2018
Financial News

Partner Therapeutics raises $60M, in-licenses Leukine

...rights to Leukine sargramostim from Sanofi (Euronext:SAN; NYSE:SNY). Fellow new investors Adams St. Partners and MidCap Financial...
BioCentury | Feb 2, 2018
Company News

Partner Therapeutics raises $60M, in-licenses Leukine

...rights to Leukine sargramostim from Sanofi (Euronext:SAN; NYSE:SNY). Fellow new investors Adams St. Partners and MidCap Financial...
BioCentury | Jan 5, 2018
Financial News

Bioinformatics company DNAnexus raises $58M in financing

...as did existing investors GV, TPG Biotech, WuXi NextCode Genomics Inc., Claremont Creek Ventures and MidCap Financial...
BioCentury | Jan 2, 2018
Financial News

Bioinformatics company DNAnexus raises $58M

...as did existing investors GV, TPG Biotech, WuXi NextCode Genomics Inc., Claremont Creek Ventures and MidCap Financial...
BioCentury | Jul 21, 2017
Financial News

Sarepta secures $100M debt facility

...July 18, musculoskeletal company Sarepta Therapeutics Inc. (NASDAQ:SRPT) secured a $100 million debt facility with MidCap Financial...
BioCentury | Jul 19, 2017
Company News

Sarepta launches Exondys 51 managed access program

...year. It is under EMA review. Separately, Sarepta secured a $100 million debt facility with MidCap Financial...
BioCentury | Oct 31, 2016
Financial News

AxoGen Inc. completes debt financing

...NASDAQ:AXGN), Alachua, Fla. Business: Neurology Date completed: 2016-10-26 Type: Debt financing Raised: $21 million Investor: MidCap Financial...
BioCentury | Oct 31, 2016
Financial News

AxoGen Inc. completes debt financing

...NASDAQ:AXGN), Alachua, Fla. Business: Neurology Date completed: 2016-10-26 Type: Debt financing Raised: $4 million Investor: MidCap Financial...
BioCentury | Oct 24, 2016
Financial News

Quotient completes private placement of senior notes

...The company plans to use a portion of the proceeds to repay its loan from MidCap Financial...
BioCentury | Oct 10, 2016
Financial News

Oxford Immunotec Global financial update

...secured a $30 million term loan and a $10 million revolving line of credit with MidCap Financial...
Items per page:
1 - 10 of 62
BioCentury | Feb 2, 2018
Financial News

Partner Therapeutics raises $60M, in-licenses Leukine

...rights to Leukine sargramostim from Sanofi (Euronext:SAN; NYSE:SNY). Fellow new investors Adams St. Partners and MidCap Financial...
BioCentury | Feb 2, 2018
Company News

Partner Therapeutics raises $60M, in-licenses Leukine

...rights to Leukine sargramostim from Sanofi (Euronext:SAN; NYSE:SNY). Fellow new investors Adams St. Partners and MidCap Financial...
BioCentury | Jan 5, 2018
Financial News

Bioinformatics company DNAnexus raises $58M in financing

...as did existing investors GV, TPG Biotech, WuXi NextCode Genomics Inc., Claremont Creek Ventures and MidCap Financial...
BioCentury | Jan 2, 2018
Financial News

Bioinformatics company DNAnexus raises $58M

...as did existing investors GV, TPG Biotech, WuXi NextCode Genomics Inc., Claremont Creek Ventures and MidCap Financial...
BioCentury | Jul 21, 2017
Financial News

Sarepta secures $100M debt facility

...July 18, musculoskeletal company Sarepta Therapeutics Inc. (NASDAQ:SRPT) secured a $100 million debt facility with MidCap Financial...
BioCentury | Jul 19, 2017
Company News

Sarepta launches Exondys 51 managed access program

...year. It is under EMA review. Separately, Sarepta secured a $100 million debt facility with MidCap Financial...
BioCentury | Oct 31, 2016
Financial News

AxoGen Inc. completes debt financing

...NASDAQ:AXGN), Alachua, Fla. Business: Neurology Date completed: 2016-10-26 Type: Debt financing Raised: $21 million Investor: MidCap Financial...
BioCentury | Oct 31, 2016
Financial News

AxoGen Inc. completes debt financing

...NASDAQ:AXGN), Alachua, Fla. Business: Neurology Date completed: 2016-10-26 Type: Debt financing Raised: $4 million Investor: MidCap Financial...
BioCentury | Oct 24, 2016
Financial News

Quotient completes private placement of senior notes

...The company plans to use a portion of the proceeds to repay its loan from MidCap Financial...
BioCentury | Oct 10, 2016
Financial News

Oxford Immunotec Global financial update

...secured a $30 million term loan and a $10 million revolving line of credit with MidCap Financial...
Items per page:
1 - 10 of 62